Touch Immunology

  • Home
  • Touch Immunology

Touch Immunology touchIMMUNOLOGY is proud to be at the forefront of on-demand and virtual formats, pushing the bounda

This information is intended for use by licensed Healthcare Professionals (HCPs). It should not be considered medical advice, diagnosis, or treatment recommendations. The information posted on this channel is intended for use by licensed Healthcare Professionals (HCPs).

15/07/2025

Polish up your knowledge and stay current with the latest in diagnosing and treating fungal nail infections.

From AI and PCR to lasers, microwaves, and emerging topical and systemic therapies, the tools for diagnosing and treating onychomycosis are evolving.

In this expert-led update, Dr Shari Lipner explores:
🔍 Smarter diagnostics and how they are improving accuracy
💊 When and how best to use topical, oral or combination therapies
⚡ New antifungals and devices gaining ground
🛡️ How to reduce relapse with simple strategies

👉 Listen here: https://touchderma.com/podcast/diagnosing-and-treating-onychomycosis/

🧠 Exploring the Future of OA Research with Dr Tom AppletonIn this Future Leaders interview, Dr Tom Appleton shares his j...
11/07/2025

🧠 Exploring the Future of OA Research with Dr Tom Appleton

In this Future Leaders interview, Dr Tom Appleton shares his journey as a clinician-scientist and his work uncovering the inflammatory pathways driving OA. Based at Western University, his research is paving the way for more targeted, patient-focused therapies.

Read the full interview for insights on translational science, career advice for early-career rheumatologists, and the evolving role of immunology in OA treatment.

👉 https://touchimmunology.com/insight/advancing-osteoarthritis-research-through-immunology-and-clinical-insight/

🧠 Bridging Research and Practice in Hepatology 🩺Chronic liver disease is on the rise across Europe — yet many patients s...
11/07/2025

🧠 Bridging Research and Practice in Hepatology 🩺

Chronic liver disease is on the rise across Europe — yet many patients still face delayed diagnoses, unequal access to care, and limited treatment options.

We spoke with Prof. Debbie Shawcross (King’s College London), Secretary General of EASL, about how the European Association for the Study of the Liver is tackling these challenges head-on.

In this interview, Prof. Shawcross explores:
🔬 How EASL is translating cutting-edge research into clinical practice
🧭 Strategies to close care gaps and improve early diagnosis
💡 Initiatives like Healthy Livers Healthy Lives and World Liver Day
🤝 The role of multidisciplinary collaboration

📍 Read more: https://touchimmunology.com/insight/easls-approach-to-liver-disease-in-europe/

🔍 Understanding Hypermobility Spectrum Disorders and PainHypermobility Spectrum Disorders (HSDs) involve more than just ...
10/07/2025

🔍 Understanding Hypermobility Spectrum Disorders and Pain

Hypermobility Spectrum Disorders (HSDs) involve more than just joint laxity—they affect multiple systems and can lead to musculoskeletal pain, dysautonomia, and emotional distress.

This review highlights new tools like the Spider Questionnaire for comprehensive symptom assessment and stresses the importance of a multidisciplinary approach to manage these complex conditions effectively.

Explore how recent developments can improve diagnosis and treatment in clinical practice:
https://touchimmunology.com/rheumatology/journal-articles/hypermobility-spectrum-disorders-and-pain-a-review-of-recent-developments-and-their-application-to-clinical-practice/

🔬 Advancing Vasculitis Care & Education with Dr Brian JarosDr Brian Jaros, Associate Program Director at Northwestern’s ...
09/07/2025

🔬 Advancing Vasculitis Care & Education with Dr Brian Jaros

Dr Brian Jaros, Associate Program Director at Northwestern’s Rheumatology Fellowship and Vasculitis Center, shares how a key clinical case inspired his focus on vasculitis and shaped his approach to care and mentorship.

He highlights the importance of teamwork in managing aggressive vasculitic disease and personalised mentorship to train future rheumatologists.

📍 Read the full interview:
https://touchimmunology.com/insight/advancing-vasculitis-care-and-medical-education-an-interview-with-future-leader-dr-brian-jaros/

🔬 touchIMMUNOLOGY at EULAR 2025: Exploring the Future of Rheumatology and ImmunologyThe 2025 EULAR Congress in Barcelona...
08/07/2025

🔬 touchIMMUNOLOGY at EULAR 2025: Exploring the Future of Rheumatology and Immunology

The 2025 EULAR Congress in Barcelona united leading experts to showcase advances in immune-mediated musculoskeletal and systemic diseases. From novel biologics and CAR T-cell therapies, to precision medicine and patient-reported outcomes.

touchIMMUNOLOGY is proud to bring you exclusive interviews and expert insights from EULAR 2025, helping you stay at the forefront of immunological innovation and patient-centred practice.

Explore our coverage:
https://touchimmunology.com/insight/inside-eular-2025-breakthroughs-and-expert-perspectives-in-immunology/

🔬 Future Leaders in Focus – Dr Sonali Bracken is helping shape the next era of rheumatology by connecting B cell researc...
04/07/2025

🔬 Future Leaders in Focus – Dr Sonali Bracken is helping shape the next era of rheumatology by connecting B cell research with real-world clinical care.

In this inspiring interview, Dr Bracken shares what drew her to rheumatology, why B cells hold such promise in autoimmune diseases, & how therapies like CAR T cells could transform outcomes for patients with severe or refractory conditions.

💡 Read Q&A:
https://touchimmunology.com/insight/bridging-bench-and-bedside-future-leader-dr-sonali-bracken-on-autoimmunity-b-cell-research-and-the-future-of-rheumatology/

🦴 Can bone turnover markers transform osteoporosis care?At WCO-IOF-ESCEO 2025, the evolving clinical role of bone turnov...
03/07/2025

🦴 Can bone turnover markers transform osteoporosis care?

At WCO-IOF-ESCEO 2025, the evolving clinical role of bone turnover markers (BTMs) took centre stage. These biochemical indicators of bone remodelling are gaining traction for their value in assessing disease activity and monitoring treatment response in osteoporosis.

In this interview, Dr Stuart Silverman discusses updated consensus guidelines, the clinical relevance of BTMs, and how standardisation is paving the way for broader adoption in daily practice.

Explore the full insights👉 https://touchimmunology.com/insight/advancing-the-role-of-bone-turnover-markers-in-osteoporosis-management/

🧬 Immune checkpoint inhibitors (ICIs) are transforming cancer care—but what happens when treatment triggers inflammatory...
02/07/2025

🧬 Immune checkpoint inhibitors (ICIs) are transforming cancer care—but what happens when treatment triggers inflammatory arthritis?

In this editorial, experts outline a clinical approach to recognising and managing ICI-associated inflammatory arthritis (ICI-IA), a rising immune-related adverse event.

With varied grading systems and treatment strategies, early identification and rheumatology input are key to balancing cancer outcomes and long-term joint health.

🔍 Explore how guidance is evolving:
https://touchimmunology.com/rheumatology/journal-articles/clinical-approach-to-the-care-of-patients-with-immune-checkpoint-inhibitor-associated-inflammatory-arthritis/

🌬️ ILD in Autoimmune Disease: Why Early Screening MattersInterstitial lung disease (ILD) is a serious and often early co...
01/07/2025

🌬️ ILD in Autoimmune Disease: Why Early Screening Matters

Interstitial lung disease (ILD) is a serious and often early complication of systemic autoimmune rheumatic diseases (SARDs) like RA and systemic sclerosis.

At , Dr Muhammad Nisar highlighted the latest ACR guidelines, which recommend routine screening in high-risk patients using pulmonary function tests and HRCT.

Early detection is key to improving survival and preventing progression.

🩺 Discover how screening strategies are evolving:
🔗 https://touchimmunology.com/insight/screening-for-interstitial-lung-disease-in-systemic-autoimmune-rheumatic-diseases-muhammad-nisar-bsr-2025/

Address


Website

Alerts

Be the first to know and let us send you an email when Touch Immunology posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

  • Address
  • Alerts
  • Claim ownership or report listing

  • Want your business to be the top-listed Media Company?

Share